Accuracy of different immunoassays for diagnosis of HIT in clinical practice.

<p>Distribution of quantitative results according to presence of HIT (positive or negative heparin-induced platelet aggregation test [PAT] respectively and clinical criteria) is shown for different thresholds of the test. (A) enzyme-linked immunoassay (ELISA), (B) particle gel immunoassay (PaGIA), and (C) IgG-specific chemiluminescent immunoassay (AcuStar HIT-IgG).</p

Diagnostic accuracy of immunoassays according to PAT result.

<p>Diagnostic accuracy of immunoassays according to PAT result.</p

Flow of participants.

<p>Flow of participants.</p

Immunoassay results according to the presence of HIT.

<p>Immunoassay results according to the presence of HIT.</p

Patient characteristics according to the presence of HIT.

<p>Patient characteristics according to the presence of HIT.</p

Baseline characteristics of the study cohort.

<p>Baseline characteristics of the study cohort.</p

Mortality of PSM study cohort.

<p>CI, confidence interval.</p

Survival estimates with regard to indications of oral anticoagulation, age, and sex.

<p>Survival estimates with regard to indications of oral anticoagulation, age, and sex.</p

Major bleedings by indications of oral anticoagulation, age, and sex.

<p>Major bleedings by indications of oral anticoagulation, age, and sex.</p

Thromboembolic complications by indications of oral anticoagulation, age, and sex.

<p>Thromboembolic complications by indications of oral anticoagulation, age, and sex.</p